Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Upgraded at Barclays

Barclays upgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) to a strong-buy rating in a research report sent to investors on Tuesday morning,Zacks.com reports.

Several other research analysts have also recently issued reports on the stock. Jefferies Financial Group cut shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “buy” rating to a “hold” rating in a report on Monday, October 21st. Berenberg Bank lowered Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a report on Friday, October 25th. Finally, UBS Group cut Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a research report on Thursday, December 19th.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Stock Performance

Shares of MURGY stock opened at $10.98 on Tuesday. The stock’s 50-day moving average is $10.43 and its two-hundred day moving average is $10.37. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.12 and a current ratio of 1.12. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1 year low of $8.40 and a 1 year high of $11.20. The firm has a market cap of $73.43 billion, a price-to-earnings ratio of 7.14, a PEG ratio of 1.73 and a beta of 1.02.

About Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.